Biohaven Ltd. (BHVN) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-03-19

Key Insights

Insider Kishan Mehta has disposed of 17,342 common shares of Biohaven Ltd. (BHVN), while also acquiring 17,342 shares indirectly through a family trust.
Mehta maintains direct ownership of 5,320 shares and indirect ownership of 17,342 shares through the trust, indicating ongoing involvement with the company.
The transaction suggests some portfolio rebalancing by Mehta, but the overall insider ownership position remains substantial, potentially signaling confidence in the company's prospects.

Want the newest filings?

This analysis covers the filing from 2026-03-19. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-01-07

George C. Clark, VP and Chief Accounting Officer, has exercised 2,500 restricted share units and disposed of 1,117 shares to cover tax withholding, indicating ongoing equity ownership in the company.
Clark's indirect beneficial ownership of 20,000 common shares through an IRA suggests a long-term investment in Biohaven Ltd.
The vesting schedule of the restricted share units, with 2,500 shares vesting annually over the next 4 years, aligns Clark's incentives with long-term shareholder value creation.

Filed: 2026-01-07

The reporting person, Bruce Car, the Chief Scientific Officer of Biohaven Ltd., exercised 4,750 restricted share units and had 2,381 shares withheld to cover tax obligations, resulting in a net increase of 2,369 shares in his direct ownership.
Bruce Car also holds 30,000 Biohaven shares indirectly through an IRA, indicating he has a significant stake in the company.
The restricted share units were granted in January 2025 and vest in four equal installments over four years, aligning the reporting person's interests with long-term shareholder value creation.

Filed: 2026-01-07

The CEO, Vlad Coric, has exercised 14,250 restricted share units and sold 7,430 shares to cover tax withholding, indicating continued commitment to the company.
Coric owns a significant stake in Biohaven, with over 1.8 million shares held directly and another 2 million indirectly through family trusts, suggesting alignment with shareholder interests.
The vesting schedule of Coric's restricted share units, with four equal installments over the next four years, provides long-term incentive for the CEO to drive the company's success.

Filed: 2026-01-07

The reporting person, Matthew Buten, acquired 4,250 common shares of Biohaven Ltd. (BHVN) through the vesting of restricted share units on 01/05/2026.
Buten also had 2,594 shares withheld by the issuer to satisfy tax withholding requirements related to the vesting of the restricted share units.
Following the reported transaction, Buten beneficially owns 195,652 shares of Biohaven Ltd. common stock, including shares acquired through the employee share purchase plan.

Filed: 2026-01-07

Kimberly Gentile, the SVP of Clinical Operations at Biohaven Ltd. (BHVN), exercised 3,750 restricted share units and had 1,956 shares withheld to cover tax obligations, indicating continued confidence in the company's long-term prospects.
The insider transaction suggests Biohaven's management team believes in the company's growth potential, as Gentile's stake in the company increased to over 99,500 shares.
The vesting schedule of the restricted share units, with four equal installments over the next four years, aligns the executive's interests with long-term shareholder value creation.

Other reports for Biohaven Ltd.

Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.